Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors
Clinical trial NCT06107608 · RECRUITING
Trial details
- NCT number
- NCT06107608
- Sponsor
- Jules Bordet Institute
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-13
- Primary completion
- 2027-07-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.